In 2023, Dipal Doshi earned $968.21K in total compensation at Entrada Therapeutics, including $585.00K salary and $370.01K bonus. Most recently sold 1,900 shares in Jul 2024. Currently holds stock worth $4.31M. Led Entrada Therapeutics as CEO for 2 years.
Compensation History
Annual executive compensation data for Dipal Doshi, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$968.21K
Salary
$585.00K
Bonus
$370.01K
Other
$13.20K
Salary
$585.00KBoard Justification
The compensation committee aims to align executive compensation with company performance and market benchmarks to attract and retain top talent.
Bonus
$370.01KBoard Justification
Annual bonuses paid for performance during the year ended December 31, 2023, based on achievement of certain Company performance metrics.
Other Compensation
$13.20KBoard Justification
Employer matching contribution to the executive’s 401(k) plan contributions during the relevant year.
Restricted Stock
Board Justification
No stock was reported as vested in 2023.
Performance Metrics
Performance metrics for bonuses are based on financial and operational measures or objectives.
Dipal Doshi
Ex-CEO of Entrada Therapeutics
Education
MBA from Harvard Business School
Sector of Economy
Healthcare
Born
January 1, 1978 - 47 years ago
CEO of Entrada Therapeutics for
2 years 10 months (Mar 2021 - Jan 2024)
Previous Experience
Formerly held positions at various biopharmaceutical companies
Other Entrada Therapeutics CEOs
Holdings
Track Dipal Doshi's stock holdings and portfolio value over time.
Total Stock Sold
$1.47M
$1.38M
86,992 TRDA shares
$86.06K
6,250 FOLD shares
What if they kept their stock?
If Dipal Doshi didn't sell their stock, today they would have:
Extra TRDA86,992 shares worth $897.76K and FOLD6,250 shares worth $61.88K.
This is -34.58% and $507.28K less than what they got when they sold the stock.
Insider Trading
Dipal Doshi's recent stock transactions, purchases, and sales filed with the SEC.
$34.02K
TRDA at $17.91/share
Jul 12, 2024
Sale
$16.17K
TRDA at $16.17/share
Jun 13, 2024
Sale
$45.16K
TRDA at $15.05/share
May 16, 2024
Sale
104,700 shares
TRDA
Mar 1, 2024
Received
$15.00K
TRDA at $15.00/share
Feb 15, 2024
Sale
$15.99K
TRDA at $15.99/share
Jan 16, 2024
Sale
$15.00K
TRDA at $15.00/share
Dec 20, 2023
Sale
$16.23K
TRDA at $16.23/share
Nov 13, 2023
Sale
$15.00K
TRDA at $15.00/share
Oct 17, 2023
Sale
$15.00K
TRDA at $15.00/share
Sep 13, 2023
Sale
Rivals
Compare Dipal Doshi with competitor CEOs and industry peers.